Atherectomy Clinical Trials

Clinical trials related to Atherectomy Procedure

ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

ORACLE is a Europe-wide study that will follow 250 people with critical limb-threatening ischemia (CLTI). It aims to see how well orbital atherectomy (OA) works in real-life practice. OA is a procedure that uses a tiny spinning tool to gently remove hard calcium from inside an artery, helping to open the vessel so other treatments-like balloons or stents-can work better. The study focuses on people who have heavily calcified arteries in the femoropopliteal or infrapopliteal areas of the leg.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Rutherford classification category ≥4;

• Treatment of femoropopliteal or infrapopliteal calcified lesions with OA using the Stealth 360 peripheral OA System;

• Calcification of target lesions must be visible on fluoroscopy or CT-angiography;

• Patients competent and willing to provide informed consent.

Locations
Other Locations
United Kingdom
Hull University Teaching Hospitals NHS Trust
RECRUITING
Hull
Contact Information
Primary
Claire Poulet, PhD
oracue@cirse.org
+41 79 385 16 78
Backup
Dhwani S. Korde, PhD
oracue@cirse.org
+4367762942469
Time Frame
Start Date: 2026-08-31
Estimated Completion Date: 2031-12
Participants
Target number of participants: 250
Treatments
Adult CLTI patients with femoropopliteal or infrapopliteal calcified lesions
Eligible patients are those who will undergo OA prior to any adjunctive endovascular procedure
Related Therapeutic Areas
Sponsors
Leads: Cardiovascular and Interventional Radiological Society of Europe
Collaborators: Abbott

This content was sourced from clinicaltrials.gov